Poor prognosis ofKRASorBRAFmutant colorectal liver metastasis without microsatellite instability
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Poor prognosis ofKRASorBRAFmutant colorectal liver metastasis without microsatellite instability
Authors
Keywords
Colorectal cancer, Liver metastasis, KRAS, BRAF, Microsatellite instability
Journal
Journal of Hepato-Biliary-Pancreatic Sciences
Volume 20, Issue 2, Pages 223-233
Publisher
Wiley
Online
2012-07-20
DOI
10.1007/s00534-012-0531-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Microsatellite Instability and Colorectal Cancer
- (2011) Katherine B. Geiersbach et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- BRAF mutation is a powerful prognostic factor in advanced and recurrent colorectal cancer
- (2011) T Yokota et al. BRITISH JOURNAL OF CANCER
- Microsatellite Instability in Colorectal Cancer
- (2010) C. Richard Boland et al. GASTROENTEROLOGY
- An Optimized Pentaplex PCR for Detecting DNA Mismatch Repair-Deficient Colorectal Cancers
- (2010) Ajay Goel et al. PLoS One
- Long-Term Outcome of Initially Unresectable Metastatic Colorectal Cancer Patients Treated with 5-Fluorouracil/Leucovorin, Oxaliplatin, and Irinotecan (FOLFOXIRI) Followed by Radical Surgery of Metastases
- (2009) Gianluca Masi et al. ANNALS OF SURGERY
- Deficient mismatch repair system in patients with sporadic advanced colorectal cancer
- (2009) M Koopman et al. BRITISH JOURNAL OF CANCER
- KRAS Mutation in Stage III Colon Cancer and Clinical Outcome Following Intergroup Trial CALGB 89803
- (2009) S. Ogino et al. CLINICAL CANCER RESEARCH
- Hidden Biases in an Observational Study of Bevacizumab Beyond Progression
- (2009) Scott Kopetz et al. JOURNAL OF CLINICAL ONCOLOGY
- KRASandBRAFMutations in Advanced Colorectal Cancer Are Associated With Poor Prognosis but Do Not Preclude Benefit From Oxaliplatin or Irinotecan: Results From the MRC FOCUS Trial
- (2009) Susan D. Richman et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Role of KRAS and BRAF in Stage II and III Resected Colon Cancer: Results of the Translational Study on the PETACC-3, EORTC 40993, SAKK 60-00 Trial
- (2009) Arnaud D. Roth et al. JOURNAL OF CLINICAL ONCOLOGY
- BRAFMutation in Metastatic Colorectal Cancer
- (2009) Jolien Tol et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical relevance of EGFR- and KRAS-status in colorectal cancer patients treated with monoclonal antibodies directed against the EGFR
- (2008) Volker Heinemann et al. CANCER TREATMENT REVIEWS
- K-Ras Mutations and Treatment Outcome in Colorectal Cancer Patients Receiving Exclusive Fluoropyrimidine Therapy
- (2008) M.-C. Etienne-Grimaldi et al. CLINICAL CANCER RESEARCH
- Prognostic Significance of Defective Mismatch Repair and BRAF V600E in Patients with Colon Cancer
- (2008) A. J. French et al. CLINICAL CANCER RESEARCH
- Mutations in Both KRAS and BRAF May Contribute to the Methylator Phenotype in Colon Cancer
- (2008) Takeshi Nagasaka et al. GASTROENTEROLOGY
- Wild-TypeKRASIs Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer
- (2008) Rafael G. Amado et al. JOURNAL OF CLINICAL ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started